These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 24626127)

  • 1. Oropharyngeal squamous cell carcinoma treatment: current standards and future directions.
    Marur S; Burtness B
    Curr Opin Oncol; 2014 May; 26(3):252-8. PubMed ID: 24626127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus as a marker of the natural history and response to therapy of head and neck squamous cell carcinoma.
    Ang KK; Sturgis EM
    Semin Radiat Oncol; 2012 Apr; 22(2):128-42. PubMed ID: 22385920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HPV-positive head and neck tumours, a distinct clinical entity.
    Nevens D; Nuyts S
    B-ENT; 2015; 11(2):81-7. PubMed ID: 26563006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
    Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
    Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma.
    Oguejiofor KK; Hall JS; Mani N; Douglas C; Slevin NJ; Homer J; Hall G; West CM
    Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):630-8. PubMed ID: 23916365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term prognosis and risk factors among patients with HPV-associated oropharyngeal squamous cell carcinoma.
    Lin BM; Wang H; D'Souza G; Zhang Z; Fakhry C; Joseph AW; Drake VE; Sanguineti G; Westra WH; Pai SI
    Cancer; 2013 Oct; 119(19):3462-71. PubMed ID: 23861037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of cisplatin dose intensity on human papillomavirus-related and -unrelated locally advanced head and neck squamous cell carcinoma.
    Spreafico A; Huang SH; Xu W; Granata R; Liu CS; Waldron JN; Chen E; Ringash J; Bayley A; Chan KK; Hope AJ; Cho J; Razak AA; Hansen A; Jang R; Perez-Ordonez B; Weinreb I; Bossi P; Orlandi E; Licitra LF; Song Y; O'Sullivan B; Siu LL; Kim J
    Eur J Cancer; 2016 Nov; 67():174-182. PubMed ID: 27669504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiographic retropharyngeal lymph node involvement in HPV-associated oropharyngeal carcinoma: Patterns of involvement and impact on patient outcomes.
    Lin TA; Garden AS; Elhalawani H; Elgohari B; Jethanandani A; Ng SP; Mohamed AS; Frank SJ; Glisson BS; Debnam JM; Sturgis EM; Phan J; Reddy JP; Fuller CD; Morrison WH; Skinner HD; Rosenthal DI; Gunn GB
    Cancer; 2019 May; 125(9):1536-1546. PubMed ID: 30620385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The New Face of Head and Neck Cancer: The HPV Epidemic.
    Lewis A; Kang R; Levine A; Maghami E
    Oncology (Williston Park); 2015 Sep; 29(9):616-26. PubMed ID: 26384796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current Status and Future Directions of Treatment Deintensification in Human Papilloma Virus-associated Oropharyngeal Squamous Cell Carcinoma.
    Chera BS; Amdur RJ
    Semin Radiat Oncol; 2018 Jan; 28(1):27-34. PubMed ID: 29173753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of human papillomavirus on the prognosis and treatment of oropharyngeal carcinoma.
    Fung N; Faraji F; Kang H; Fakhry C
    Cancer Metastasis Rev; 2017 Sep; 36(3):449-461. PubMed ID: 28812214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HPV-related Oropharyngeal Carcinoma: A Review of Clinical and Pathologic Features With Emphasis on Updates in Clinical and Pathologic Staging.
    Buckley L; Jackett L; Clark J; Gupta R
    Adv Anat Pathol; 2018 May; 25(3):180-188. PubMed ID: 29394171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p16 immunohistochemistry in oropharyngeal squamous cell carcinoma: a comparison of antibody clones using patient outcomes and high-risk human papillomavirus RNA status.
    Shelton J; Purgina BM; Cipriani NA; Dupont WD; Plummer D; Lewis JS
    Mod Pathol; 2017 Sep; 30(9):1194-1203. PubMed ID: 28621317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of human papillomavirus on outcome in patients with oropharyngeal cancer treated with primary surgery.
    Broglie MA; Stoeckli SJ; Sauter R; Pasche P; Reinhard A; de Leval L; Huber GF; Pezier TF; Soltermann A; Giger R; Arnold A; Dettmer M; Arnoux A; Müller M; Spreitzer S; Lang F; Lutchmaya M; Stauffer E; Espeli V; Martucci F; Bongiovanni M; Foerbs D; Jochum W
    Head Neck; 2017 Oct; 39(10):2004-2015. PubMed ID: 28691255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab.
    Rosenthal DI; Harari PM; Giralt J; Bell D; Raben D; Liu J; Schulten J; Ang KK; Bonner JA
    J Clin Oncol; 2016 Apr; 34(12):1300-8. PubMed ID: 26712222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACR Appropriateness Criteria(®) Locoregional therapy for resectable oropharyngeal squamous cell carcinomas.
    Beitler JJ; Quon H; Jones CU; Salama JK; Busse PM; Cooper JS; Koyfman SA; Ridge JA; Saba NF; Siddiqui F; Smith RV; Worden F; Yao M; Yom SS;
    Head Neck; 2016 Sep; 38(9):1299-309. PubMed ID: 27330003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is the best treatment for patients with human papillomavirus-positive and -negative oropharyngeal cancer?
    Urban D; Corry J; Rischin D
    Cancer; 2014 May; 120(10):1462-70. PubMed ID: 24578320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPV in oropharyngeal cancer: the basics to know in clinical practice.
    Elrefaey S; Massaro MA; Chiocca S; Chiesa F; Ansarin M
    Acta Otorhinolaryngol Ital; 2014 Oct; 34(5):299-309. PubMed ID: 25709145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus: changing paradigms in oropharyngeal cancer.
    Adelstein DJ; Rodriguez CP
    Curr Oncol Rep; 2010 Mar; 12(2):115-20. PubMed ID: 20425596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus integration pattern and demographic, clinical, and survival characteristics of patients with oropharyngeal squamous cell carcinoma.
    Lim MY; Dahlstrom KR; Sturgis EM; Li G
    Head Neck; 2016 Aug; 38(8):1139-44. PubMed ID: 27002307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.